Nanoparticle-target interactions parallel antibody-protein interactions
about
Magnetomotive molecular nanoprobes.Magnetic nanoparticle biosensors.Environment-responsive nanophores for therapy and treatment monitoring via molecular MRI quenching.Magnetic nanoparticles for biomedical NMR-based diagnosticsMagnetic nanoparticles in magnetic resonance imaging and diagnostics.Particles and microfluidics merged: perspectives of highly sensitive diagnostic detection.Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticlesMechanism of magnetic relaxation switching sensingColloidal nanomaterial-based immunoassay.Triggering the apoptosis of targeted human renal cancer cells by the vibration of anisotropic magnetic particles attached to the cell membrane.Working principle and application of magnetic separation for biomedical diagnostic at high- and low-field gradients.Direct coupling of annexin A5 to VSOP yields small, protein-covered nanoprobes for MR imaging of apoptosis.Detection of lysozyme magnetic relaxation switches based on aptamer-functionalized superparamagnetic nanoparticlesMagnetic nanoparticle sensors.Resistive pulse sensing of magnetic beads and supraparticle structures using tunable pores.Rapid, highly sensitive detection of herpes simplex virus-1 using multiple antigenic peptide-coated superparamagnetic beads.Fluorochrome-functionalized magnetic nanoparticles for high-sensitivity monitoring of the polymerase chain reaction by magnetic resonance.Antibody-biotemplated HgS nanoparticles: extremely sensitive labels for atomic fluorescence spectrometric immunoassay.T2 magnetic resonance enables nanoparticle-mediated rapid detection of candidemia in whole blood.Relaxivity control of magnetic nanoclusters for efficient magnetic relaxation switching assay
P2860
Q30468740-3EADD388-5A1C-4842-86AD-BB93C9EAA870Q33545705-5E29D788-04ED-47B1-B9AB-C05A3F33A9EFQ33939863-426B1947-EABC-471F-AE28-954E8A811F65Q34041643-41C6257B-DD36-4E38-9C13-D0D818CC809AQ34185314-B869700C-847F-40C4-9D50-DCE3A71DF2A6Q34447531-ECD44DD5-73FE-4C7C-A41C-30B750640FC9Q36070187-909CEE4C-16D6-42D5-B8BF-B12887AFA02AQ36195073-A485FED1-0AF5-44A9-9E63-4F153BF5C122Q38021820-55D7854C-31AE-40E5-BF78-D5265FDE6D42Q38835711-7BB59EFC-CCC2-49B8-936C-F22E74A23A99Q39030220-48E410B0-92A6-4D27-B427-6CC5BB297E16Q39214883-8024DA1A-08B3-4ADE-9FAD-4D1294B59A80Q39480291-20FFC303-3932-4563-8F38-A3CF75546476Q40013971-F2048B4E-DE79-4C82-A7E9-6C5B31588F5DQ41967349-C2E58655-8099-43DB-A0B9-C980CE186286Q42185132-32BF35EB-B536-4EB6-9062-8BED9FC28ABBQ42410673-D198FB13-D982-4BD5-A85E-34A82046DB47Q50502935-E72CB3CB-5EC2-487B-B5D0-A82F2DAD0FD8Q54262285-93C2F965-3C03-43AD-BFE8-FA5B689DC8E5Q57376535-9F33E9BC-CBC8-460A-A074-1DF1250DA6E0
P2860
Nanoparticle-target interactions parallel antibody-protein interactions
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Nanoparticle-target interactions parallel antibody-protein interactions
@en
type
label
Nanoparticle-target interactions parallel antibody-protein interactions
@en
prefLabel
Nanoparticle-target interactions parallel antibody-protein interactions
@en
P2093
P2860
P356
P1433
P1476
Nanoparticle-target interactions parallel antibody-protein interactions
@en
P2093
Lee Josephson
P2860
P304
P356
10.1021/AC802717C
P407
P577
2009-05-01T00:00:00Z